BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing

Summary

This is a narrative review, not an original experiment. Authors from the Department of Pharmacology at the University of Zagreb compare the stable gastric pentadecapeptide BPC 157, which they note is always given alone, with the standard peptide angiogenic growth factors EGF, FGF and VEGF, which are often studied with carriers. They look at how healing of the gastrointestinal tract relates to healing of tissues outside the gut, namely tendon, ligament, muscle and bone, and argue that BPC 157 in practice captures the pharmacological role of these growth factors.

Key Findings

• The review covers beneficial effects obtained with free peptides or peptides with various carriers (EGF, FGF, VEGF and BPC 157) in both gastrointestinal ulcer healing and tendon, ligament, muscle and bone healing
• According to the authors, only BPC 157 was consistently effective in all models of acute and chronic injury of the esophagus, stomach, duodenum and lower gastrointestinal tract, whether given intraperitoneally, orally or locally
• For tendon, muscle and bone injury, most growth-factor studies show increased presence of those factors alongside the procedures used; in vitro studies are fewer, and in vivo healing studies are limited, usually restricted to local application, with diverse carriers and delivery systems
• BPC 157, using the same regimens as in its gastrointestinal studies, improves tendon, ligament and bone healing, which the authors attribute to its own angiogenic effect

Methodology

Narrative review of published experimental studies on BPC 157 and on EGF, FGF and VEGF, given free or with carriers, in gastrointestinal and musculoskeletal injury models. The abstract does not describe a systematic search strategy.

Limitations

• Written by a single research group, and its central conclusion is framed by the authors as their own claim
• Summarizes experimental injury models; the abstract describes no human data
• Not a systematic review or meta-analysis, so study selection and quality weighting are not described

Relevance to Content

Background reference for how BPC-157’s proposed healing effects in the gut and in tendon, ligament and bone are linked through angiogenesis. Claims drawn from it should be framed as the authors’ interpretation of preclinical evidence, not as established effects in people.

See Also

• Parent compound: BPC-157